Norethisterone acetate oxime: Difference between revisions
Appearance
Content deleted Content added
Anypodetos (talk | contribs) m Stub sorting using AWB |
m Moving Category:Androgens and anabolic steroids to Category:Anabolic–androgenic steroids per Wikipedia:Categories for discussion/Log/2023 October 29#Category:Androgens and anabolic steroids |
||
(19 intermediate revisions by 10 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = |
| Verifiedfields = |
||
| Watchedfields = |
| Watchedfields = |
||
| verifiedrevid = |
| verifiedrevid = |
||
| IUPAC_name = (1''S'',2''R'',5''E'',10''R'',11''S'',14''R'',15''S'')-14- |
| IUPAC_name = (1''S'',2''R'',5''E'',10''R'',11''S'',14''R'',15''S'')-14-ethynyl-5-(hydroxyimino)-15-methyltetracyclo[8.7.0.0<sup>2,7</sup>.0<sup>11,15</sup>]heptadec-6-en-14-yl acetate |
||
| image = Norethisterone acetate oxime.svg |
| image = Norethisterone acetate oxime.svg |
||
| width = |
| width = 250px |
||
<!--Clinical data--> |
<!--Clinical data--> |
||
Line 17: | Line 18: | ||
| legal_US = |
| legal_US = |
||
| legal_status = |
| legal_status = |
||
| routes_of_administration = |
| routes_of_administration = [[Oral administration|By mouth]] |
||
| class = [[Progestogen]]; [[Progestogen ester]] |
|||
<!--Pharmacokinetic data--> |
<!--Pharmacokinetic data--> |
||
Line 24: | Line 26: | ||
| metabolism = |
| metabolism = |
||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
<!--Identifiers--> |
<!--Identifiers--> |
||
Line 30: | Line 32: | ||
| CAS_number = 20799-24-0 |
| CAS_number = 20799-24-0 |
||
| CAS_supplemental = |
| CAS_supplemental = |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = VFK4D40PMQ |
|||
| ATC_prefix = |
| ATC_prefix = |
||
| ATC_suffix = |
| ATC_suffix = |
||
Line 37: | Line 41: | ||
| ChemSpiderID_Ref = |
| ChemSpiderID_Ref = |
||
| ChemSpiderID = |
| ChemSpiderID = |
||
| synonyms = Norethindrone acetate oxime; ORF-5263; So-36; Norethisterone-3-oxime acetate; 17α-Ethynyl-19-nortestosterone 3-oxime 17β-acetate |
|||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=22 | H=29 | N=1 | O=3 |
| C=22 | H=29 | N=1 | O=3 |
||
⚫ | |||
| molecular_weight = 355.47056 g/mol |
|||
⚫ | |||
| StdInChI_Ref = |
| StdInChI_Ref = |
||
| StdInChI = 1S/C22H29NO3/c1-4-22(26-14(2)24)12-10-20-19-7-5-15-13-16(23-25)6-8-17(15)18(19)9-11-21(20,22)3/h1,13,17-20,25H,5-12H2,2-3H3/b23-16+/t17-,18+,19+,20-,21-,22-/m0/s1 |
| StdInChI = 1S/C22H29NO3/c1-4-22(26-14(2)24)12-10-20-19-7-5-15-13-16(23-25)6-8-17(15)18(19)9-11-21(20,22)3/h1,13,17-20,25H,5-12H2,2-3H3/b23-16+/t17-,18+,19+,20-,21-,22-/m0/s1 |
||
| StdInChIKey_Ref = |
| StdInChIKey_Ref = |
||
| StdInChIKey = SCTDPGXGNWEFNF-LQRGBYOBSA-N |
| StdInChIKey = SCTDPGXGNWEFNF-LQRGBYOBSA-N |
||
| synonyms = Norethisterone-3-oxime acetate |
|||
}} |
}} |
||
'''Norethisterone acetate oxime''' (developmental code names '''ORF-5263, So-36'''), or '''norethindrone acetate oxime''', is a [[steroid]]al [[progestin]] of the [[19-nortestosterone]] group |
'''Norethisterone acetate oxime''' (developmental code names '''ORF-5263, So-36'''), or '''norethindrone acetate oxime''', is a [[steroid]]al [[progestin]] of the [[19-nortestosterone]] group which was developed as a [[emergency contraception|postcoital contraceptive]] but was never marketed.<ref name="Elks2014">{{cite book | vauthors = Elks J |title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA886|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=886–}}</ref> It is the C3 [[oxime]] and C17β-[[acetate]] [[ester]] of [[norethisterone]].<ref name="Elks2014"/> |
||
==See also== |
==See also== |
||
* [[List of progestogens]] |
|||
* [[Norethisterone acetate]] |
|||
* [[List of progestogen esters]] |
|||
* [[Norethisterone enanthate]] |
|||
* [[Norgestimate]] |
|||
==References== |
==References== |
||
{{Reflist |
{{Reflist}} |
||
{{Progesterone receptor modulators}} |
{{Progesterone receptor modulators}} |
||
{{Androgen receptor modulators}} |
{{Androgen receptor modulators}} |
||
[[Category:Abandoned drugs]] |
|||
[[Category:Acetate esters]] |
[[Category:Acetate esters]] |
||
[[Category: |
[[Category:Anabolic–androgenic steroids]] |
||
[[Category:Estranes]] |
|||
[[Category:Progestogen esters]] |
|||
[[Category:Progestogens]] |
[[Category:Progestogens]] |
||
[[Category: |
[[Category:Steroid oximes]] |
||
[[Category:Ketoximes]] |
|||
{{Genito-urinary-drug-stub}} |
|||
{{ |
{{Steroid-stub}} |
||
{{steroid-stub}} |
Latest revision as of 17:47, 11 November 2023
Clinical data | |
---|---|
Other names | Norethindrone acetate oxime; ORF-5263; So-36; Norethisterone-3-oxime acetate; 17α-Ethynyl-19-nortestosterone 3-oxime 17β-acetate |
Routes of administration | By mouth |
Drug class | Progestogen; Progestogen ester |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
UNII | |
Chemical and physical data | |
Formula | C22H29NO3 |
Molar mass | 355.478 g·mol−1 |
3D model (JSmol) | |
| |
|
Norethisterone acetate oxime (developmental code names ORF-5263, So-36), or norethindrone acetate oxime, is a steroidal progestin of the 19-nortestosterone group which was developed as a postcoital contraceptive but was never marketed.[1] It is the C3 oxime and C17β-acetate ester of norethisterone.[1]
See also
[edit]References
[edit]- ^ a b Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 886–. ISBN 978-1-4757-2085-3.